Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation and copy number detection in human cancers using a custom genotyping assay.

Genomics - 1 Oct 2011

Moy Christopher, Aziz Muhammad U, Greshock Joel, Szabo Stephen, McNeil Elizabeth, Jing Junping, Conway Theresa, Degenhardt Yan, Wooster Richard, Bachman Kurtis

Abstract excerpt

Identification of biomarkers for positive and negative predictors of response to cancer therapeutics can help direct clinical strategies. However, challenges with tissue availability and costs are significant limiting factors for diagnostic assays. To address these challenges, we have customized a high-throughput single nucleotide polymorphism genotyping assay with the objective of simultaneously surveying known...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Gene Dosage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Neoplasms

Share to Oncogenes

Share to Point Mutation

Share to Polymorphism, Single Nucleotide

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 21600279
DOI: 10.1016/j.ygeno.2011.04.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation and copy number detection in human cancers using a custom genotyping assay.PMID 21600279Read ↗

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine.Semantic proximity Read ↗

High-throughput oncogene mutation profiling in human cancer.Semantic proximity Read ↗

Validation of a next-generation sequencing assay for clinical molecular oncology.Semantic proximity Read ↗

Genotyping of Frequent Mutations in Solid Tumors by PCR-Based Single-Base Extension and MassARRAY Analysis.Semantic proximity Read ↗

A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors.Semantic proximity Read ↗

Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.Semantic proximity Read ↗

Clinical Application of a Cancer Genomic Profiling Assay to Guide Precision Medicine DecisionsSemantic proximity Read ↗

Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene PanelSemantic proximity Read ↗

Single-copy detection of somatic variants from solid and liquid biopsy.Semantic proximity Read ↗

Systematic identification of mutations and copy number alterations associated with cancer patient prognosis.Semantic proximity Read ↗

Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics.Semantic proximity Read ↗

TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.